191 related articles for article (PubMed ID: 21659503)
1. Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.
Lee WY; Ling M; Anderson G; Achawal S; Thaker HK
J Med Microbiol; 2011 Oct; 60(Pt 10):1550-1552. PubMed ID: 21659503
[TBL] [Abstract][Full Text] [Related]
2. New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Gumbo T
Antimicrob Agents Chemother; 2010 Apr; 54(4):1484-91. PubMed ID: 20086150
[TBL] [Abstract][Full Text] [Related]
3. [A case of multiple intracranial tuberculoma diagnosed by open brain biopsy].
Sakuma R; Jin K; Nagai M; Kinpara T; Shiga Y; Fujihara K; Itoyama Y
Rinsho Shinkeigaku; 1997 Oct; 37(10):895-9. PubMed ID: 9490900
[TBL] [Abstract][Full Text] [Related]
4. A case of multi-drug-resistant, intracranial tuberculomas, presenting with headache.
Yurekli VA; Kaya O; Aydin FI; Bircan HA; Kutluhan SL; Kayan M; Gonen I
Indian J Pathol Microbiol; 2013; 56(4):481-3. PubMed ID: 24441261
[No Abstract] [Full Text] [Related]
5. Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Nuermberger E; Tyagi S; Tasneen R; Williams KN; Almeida D; Rosenthal I; Grosset JH
Antimicrob Agents Chemother; 2008 Apr; 52(4):1522-4. PubMed ID: 18285479
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
[TBL] [Abstract][Full Text] [Related]
7. Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?
Mohapatra PR
Am J Respir Crit Care Med; 2009 Oct; 180(7):686; author reply 686-7. PubMed ID: 19762595
[No Abstract] [Full Text] [Related]
8. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Rosenthal IM; Zhang M; Williams KN; Peloquin CA; Tyagi S; Vernon AA; Bishai WR; Chaisson RE; Grosset JH; Nuermberger EL
PLoS Med; 2007 Dec; 4(12):e344. PubMed ID: 18092886
[TBL] [Abstract][Full Text] [Related]
9. Intracranial lesion increase under anti-tuberculous therapy.
Alay H; Albayrak A
Rev Soc Bras Med Trop; 2020; 53():e20200112. PubMed ID: 32491102
[No Abstract] [Full Text] [Related]
10. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
11. Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.
Veziris N; Lounis N; Chauffour A; Truffot-Pernot C; Jarlier V
Antimicrob Agents Chemother; 2005 Oct; 49(10):4015-9. PubMed ID: 16189074
[TBL] [Abstract][Full Text] [Related]
12. [Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
Ruggeri C; Valenzise M; Alosi MM; Scibilia G; Wasniewska M
Minerva Pediatr; 2005 Oct; 57(5):329-32. PubMed ID: 16205620
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic dilemma and therapeutic non-compliance in a case of intracranial tuberculoma.
Ellis ME; Halim MA; Coates RK; al-Hokail AA; Hussain Qadri SM; el-Yazigi A
Tubercle; 1991 Dec; 72(4):299-303. PubMed ID: 1811363
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin].
Perel'man MI; Cokolova GB; Mozhokina GN; Lazareva IaV; Strekchev AIu; Elistratova NA
Antibiot Khimioter; 2004; 49(6):20-4. PubMed ID: 15628798
[TBL] [Abstract][Full Text] [Related]
15. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
[TBL] [Abstract][Full Text] [Related]
16. Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Rosenthal IM; Williams K; Tyagi S; Peloquin CA; Vernon AA; Bishai WR; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2006 Jul; 174(1):94-101. PubMed ID: 16574936
[TBL] [Abstract][Full Text] [Related]
17. Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.
Chauny JV; Lorrot M; Prot-Labarthe S; De Lauzanne A; Doit C; Géréral T; Bourdon O
Pediatr Infect Dis J; 2012 Dec; 31(12):1309-11. PubMed ID: 22814964
[TBL] [Abstract][Full Text] [Related]
18. Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.
Drusano GL; Sgambati N; Eichas A; Brown D; Kulawy R; Louie A
mBio; 2011; 2(4):e00108-11. PubMed ID: 21750119
[TBL] [Abstract][Full Text] [Related]
19. A Clinical Study of Miliary Brain Tuberculomas in China.
Yang M; Zhang JT; Yao Y; Tan QC; Gao T; Tian CL; Huang X; Yu SY
Jpn J Infect Dis; 2016 May; 69(3):231-5. PubMed ID: 26255731
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis.
Wong KK; Oliver GF
Australas J Dermatol; 2010 Feb; 51(1):39-41. PubMed ID: 20148841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
